E. Iliodromitis

发表

The Natural Olive Constituent Oleuropein Induces Nutritional Cardioprotection in Normal and Cholesterol-Fed Rabbits: Comparison with Preconditioning

I. Andreadou, D. Benaki, P. Efentakis, 2014, Planta Medica.

Vascular conditioning prevents adverse left ventricular remodelling after acute myocardial infarction: a randomised remote conditioning study

M. Gazouli, J. Lekakis, I. Andreadou, 2021, Basic Research in Cardiology.

Estrogen alone or combined with medroxyprogesterone but not raloxifene reduce myocardial infarct size.

E. Iliodromitis, D. Kremastinos, Z. Kyriakides, 2003, European journal of pharmacology.

The effects of 5-HT4 receptor blockade and stimulation, during six hours of atrial fibrillation.

E. Iliodromitis, D. Kremastinos, G. Theodorakis, 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Effect of hypercholesterolaemia on myocardial function, ischaemia–reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning

Z. Giricz, P. Ferdinandy, I. Andreadou, 2017, British journal of pharmacology.

Heat stress limits infarct size in the isolated perfused rabbit heart.

R. Ferrari, E. Iliodromitis, M. Marber, 1993, Cardiovascular research.

Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery

N. Kalia, H. Bøtker, J. Downey, 2016, Basic Research in Cardiology.

Pre- Peri- Post-Conditioning the Ischemic Myocardium: Challenges, Confounders and Expectations

N. Dagres, I. Andreadou, E. Iliodromitis, 2015 .

What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets

Michael V. Cohen, J. Downey, N. Dagres, 2015, Journal of cardiovascular pharmacology and therapeutics.

Ischemic and Postischemic Conditioning of the Myocardium in Clinical Practice: Challenges, Expectations and Obstacles

N. Dagres, I. Andreadou, E. Iliodromitis, 2014, Cardiology.

Myocardial Protection Provided by Chronic Skeletal Muscle Ischemia Is Not Further Enhanced by Ischemic Pre- or Postconditioning

N. Dagres, I. Andreadou, Sofia-Iris Bibli, 2014, Journal of cardiovascular pharmacology and therapeutics.

Various models of cardiac conditioning in single or sequential periods of ischemia: comparative effects on infarct size and intracellular signaling.

N. Dagres, I. Andreadou, Sofia-Iris Bibli, 2013, International journal of cardiology.

Discovery of 6-[4-(6-nitroxyhexanoyl)piperazin-1-yl)]-9H-purine, as pharmacological post-conditioning agent.

I. Andreadou, A. Zoga, E. Iliodromitis, 2012, Bioorganic & medicinal chemistry.

To prevent, protect and save the ischemic heart: antioxidants revisited

I. Andreadou, E. Iliodromitis, D. Farmakis, 2009, Expert opinion on therapeutic targets.

What Is the Optimal Postconditioning Algorithm?

J. Downey, E. Iliodromitis, G. Heusch, 2009, Journal of cardiovascular pharmacology and therapeutics.

Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation

I. Andreadou, A. Zoga, E. Iliodromitis, 2010, Basic Research in Cardiology.

Remote Postconditioning is More Potent than Classic Postconditioning in Reducing the Infarct Size in Anesthetized Rabbits

A. Zoga, E. Iliodromitis, I. Paraskevaidis, 2009, Cardiovascular Drugs and Therapy.

Staccato reperfusion prevents reperfusion injury in patients undergoing coronary angioplasty: a 1-year follow-up pilot study.

I. Andreadou, E. Iliodromitis, I. Paraskevaidis, 2009, Atherosclerosis.

Treadmill exercise test with dual isotope scintigraphy documents the second window of preconditioning in humans.

E. Iliodromitis, I. Paraskevaidis, D. Farmakis, 2008, Atherosclerosis.

Design and synthesis of nitrate esters of aromatic heterocyclic compounds as pharmacological preconditioning agents.

A. Papapetropoulos, A. Pyriochou, I. Andreadou, 2008, Bioorganic & medicinal chemistry.

p38-MAPK is involved in restoration of the lost protection of preconditioning by nicorandil in vivo.

A. Zoga, E. Iliodromitis, D. Kremastinos, 2008, European journal of pharmacology.

Protection from preconditioning can be reinstated at various reperfusion intervals

E. Iliodromitis, I. Paraskevaidis, D. Kremastinos, 1996, Cardiovascular Drugs and Therapy.

Application of NMR-based metabonomics in the investigation of myocardial ischemia-reperfusion, ischemic preconditioning and antioxidant intervention in rabbits.

A. Tsantili-Kakoulidou, I. Andreadou, E. Mikros, 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Acute administration of vitamin E triggers preconditioning via K(ATP) channels and cyclic-GMP without inhibiting lipid peroxidation.

I. Andreadou, A. Zoga, E. Iliodromitis, 2006, Free radical biology & medicine.

Ischemic but not mechanical preconditioning attenuates ischemia/reperfusion induced myocardial apoptosis in anaesthetized rabbits: The role of Bcl-2 family proteins and ERK1/2

K. Voskarides, E. Iliodromitis, A. Lazou, 2006, Apoptosis.

Differential activation of mitogen-activated protein kinases in ischemic and nitroglycerin-induced preconditioning

A. Zoga, E. Iliodromitis, A. Lazou, 2006, Basic Research in Cardiology.

From preconditioning to postconditioning: novel interventions in the armory of salvage of the ischemic heart.

E. Iliodromitis, D. Kremastinos, 2006, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning?

S. Adamopoulos, S. Kyrzopoulos, E. Iliodromitis, 2006, Heart.

Repeated exercise stress testing identifies early and late preconditioning.

E. Iliodromitis, I. Paraskevaidis, D. Kremastinos, 2005, International journal of cardiology.

Preinfarction angina does not alter infarct size and in hospital outcome after acute myocardial infarction with ST elevation.

G. Liakos, E. Iliodromitis, D. Kremastinos, 2004, International journal of cardiology.

Enhanced Protection of Heat Shock in Myocardial Infarction: Inhibition of Detrimental Effect of Systemic Hyperthermia

E. Iliodromitis, D. Kremastinos, D. Yellon, 1999, Cardiovascular Drugs and Therapy.

Alterations in circulating cyclic guanosine monophosphate (c-GMP) during short and long ischemia in preconditioning

E. Iliodromitis, I. Paraskevaidis, D. Kremastinos, 1996, Basic Research in Cardiology.

Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress.

A. Tsantili-Kakoulidou, I. Andreadou, A. Zoga, 2004, Free radical biology & medicine.

Dissociation of stress-activated protein kinase (p38-MAPK and JNKs) phosphorylation from the protective effect of preconditioning in vivo.

E. Iliodromitis, D. Kremastinos, I. Beis, 2002, Journal of molecular and cellular cardiology.

The Role of Exercise Doppler Echocardiography to Unmask Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis and Equivocal Baseline Echocardiographic Values for Pulmonary Hypertension

L. Rallidis, S. Orfanos, C. Varounis, 2021, Diagnostics.

Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.

D. Sanoudou, A. Papapetropoulos, E. Kranias, 2015, Cardiovascular research.

Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry

C. Tsioufis, E. Iliodromitis, I. Xanthopoulou, 2018, Cardiovascular Drugs and Therapy.

Protection by ischaemic preconditioning appears independent of stress protein synthesis

J. Downey, E. Iliodromitis, M. Marber, 1991 .

Nitroglycerine limits infarct size through S-nitrosation of cyclophilin D: a novel mechanism for an old drug

A. Papapetropoulos, A. Daiber, I. Andreadou, 2018, Cardiovascular research.

Ischemic postconditioning: experimental models and protocol algorithms

E. Iliodromitis, G. Heusch, D. Kremastinos, 2009, Basic Research in Cardiology.

Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects

M. Brizzi, N. Kostomitsopoulos, G. Dimitriadis, 2017, Front. Physiol..

Investigating the Signal Transduction Pathways Underlying Remote Ischemic Conditioning in the Porcine Heart

D. Yellon, I. Andreadou, E. Iliodromitis, 2012, Cardiovascular Drugs and Therapy.

Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo.

I. Andreadou, A. Zoga, E. Iliodromitis, 2004, European journal of pharmacology.

Cardiopulmonary Exercise Testing: The ABC for the Clinical Cardiologist

E. Iliodromitis, H. Triantafyllidi, P. Trivilou, 2021, Cardiology.

Biological activity of the novel cyclic angiotensin II analogue [Sar1,Lys3,Glu5]ANG II

E. Iliodromitis, G. Moore, D. Kremastinos, 1996, Letters in Peptide Science.

The re-introduction of ischemic preconditioning is able to protect myocardium after repeated long reperfusion intervals.

E. Iliodromitis, I. Paraskevaidis, D. Kremastinos, 1994, Cardioscience.

Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes

J. Lekakis, G. Dimitriadis, I. Andreadou, 2018, Cardiovascular Diabetology.

PCSK9 inhibitors in clinical practice: novel directions and new experiences.

C. Vlachopoulos, L. Rallidis, D. Tousoulis, 2019, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

The effect of acute administration of statins on coronary microcirculation during the pre-revascularization period in patients with myocardial infraction.

L. Rallidis, E. Iliodromitis, I. Paraskevaidis, 2012, Atherosclerosis.

Opposite relations of epicardial adipose tissue to left atrial size in paroxysmal and permanent atrial fibrillation

E. Iliodromitis, I. Paraskevaidis, E. Gkika, 2018, SAGE open medicine.

Imaging Risk in Multisystem Inflammatory Diseases.

E. Iliodromitis, J. Parissis, D. Boumpas, 2019, JACC. Cardiovascular imaging.

Characteristics and Long-Term Prognosis of Patients ≤35 Years of Age with ST Segment Elevation Myocardial Infarction and "Normal or Near Normal" Coronary Arteries.

L. Rallidis, A. Triantafyllis, A. Gialeraki, 2017, The American journal of cardiology.

Effects of the Olive Tree Leaf Constituents on Myocardial Oxidative Damage and Atherosclerosis

N. Dagres, I. Andreadou, P. Efentakis, 2015, Planta Medica.

Arrhythmogenic Inflammatory Cardiomyopathy in Autoimmune Rheumatic Diseases: A Challenge for Cardio-Rheumatology

G. Kitas, G. Kolovou, D. Tousoulis, 2019, Diagnostics.

Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin.

M. Dimopoulos, I. Trougakos, I. Andreadou, 2019, Blood.

DDDR pacing results in left ventricular asynchrony with preservation of ejection fraction and NT-proBNP: a prospective study in sick sinus syndrome and normal ventricular function.

E. Iliodromitis, D. Kremastinos, A. Charalampopoulos, 2010, International journal of cardiology.

Ovariectomy Reinstates the Infarct Size-Limiting Effect of Postconditioning in Female Rabbits

I. Andreadou, A. Zoga, E. Iliodromitis, 2012, Cell Biochemistry and Biophysics.

Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3‐year follow‐up study

C. Varounis, E. Iliodromitis, H. Boudoulas, 2010, European journal of clinical investigation.

Osteopontinasanovelprognosticmarkerinstable ischaemicheartdisease:a3-yearfollow-upstudy

C. Varounis, E. Iliodromitis, H. Boudoulas, 2010 .

Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism.

K. Naka, I. Andreadou, Sofia-Iris Bibli, 2014, Journal of molecular and cellular cardiology.

Exposure to cigarette smoke abrogates the beneficial effect of ischemic postconditioning.

S. Zakynthinos, A. Papapetropoulos, I. Andreadou, 2016, American journal of physiology. Heart and circulatory physiology.

E. Iliodromitis, I. Ikonomidis, F. Panou, 2018 .

Short-Term Estrogen Reduces Myocardial Infarct Size in Oophororectomized Female Rabbits in a Dose-Dependent Manner

E. Iliodromitis, D. Kremastinos, Z. Kyriakides, 1998, Cardiovascular Drugs and Therapy.

Effects of Pre- and Postconditioning on Arrhythmogenesis in the In Vivo Rat Model

A. Tzallas, D. Tsalikakis, A. Zoga, 2013, Journal of Cardiovascular Pharmacology and Therapeutics.

Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12‐Month Treatment

G. Dimitriadis, I. Andreadou, E. Iliodromitis, 2020, Journal of the American Heart Association.

Primary stenting of an unprotected left main coronary artery total occlusion in a patient with acute myocardial infraction and cardiogenic shock

S. Adamopoulos, E. Iliodromitis, D. Kremastinos, 2006, Acute cardiac care.

Myocardial infarction or acute coronary syndrome with non-obstructive coronary arteries and sudden cardiac death: a missing connection

A. Manolis, N. Dagres, E. Iliodromitis, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease

G. Dimitriadis, E. Iliodromitis, J. Parissis, 2014, Cardiovascular Diabetology.

Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?

A. Vlahou, N. Kostomitsopoulos, G. Dimitriadis, 2022, Basic Research in Cardiology.

The value of physical signs in identifying patients with familial hypercholesterolemia in the era of genetic testing.

L. Rallidis, E. Iliodromitis, D. Iordanidis, 2020, Journal of cardiology.

Obesity, inflammation, and heart failure: links and misconceptions

R. Starling, F. Triposkiadis, E. Iliodromitis, 2021, Heart Failure Reviews.

Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patients.

S. Adamopoulos, E. Iliodromitis, J. Parissis, 2004, International journal of cardiology.

Whole body heat stress fails to limit infarct size in the reperfused rabbit heart.

D. Latchman, E. Iliodromitis, D. Yellon, 1992, Cardiovascular research.

Epicardial Fat in Nonalcoholic Fatty Liver Disease

E. Iliodromitis, N. Papaioannou, T. Apostolou, 2016, Angiology.

The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning

P. Ferdinandy, A. Papapetropoulos, I. Andreadou, 2015, British journal of pharmacology.

The role of gasotransmitters

P. Ferdinandy, A. Papapetropoulos, I. Andreadou, 2014 .

Transient carotid ischemia as a remote conditioning stimulus for myocardial protection in anesthetized rabbits: Insights into intracellular signaling.

I. Andreadou, P. Efentakis, Sofia-Iris Bibli, 2015, International journal of cardiology.

The Use of Oleuropein on Myocardium

I. Andreadou, A. Skaltsounis, E. Mikros, 2010 .

The Effect of the Phytoestrogen Genistein on Myocardial Protection and Preconditioning in Hypercholesterolemia

A. Zoga, E. Iliodromitis, D. Kremastinos, 2007, Cardiovascular Drugs and Therapy.

The Effect of the Phytoestrogen Genistein on Myocardial Protection, Preconditioning and Oxidative Stress

I. Andreadou, A. Zoga, E. Iliodromitis, 2006, Cardiovascular Drugs and Therapy.

Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study

I. Kallikazaros, S. Sideris, D. Tousoulis, 2019, European heart journal.

Ranolazine triggers pharmacological preconditioning and postconditioning in anesthetized rabbits through activation of RISK pathway.

N. Dagres, I. Andreadou, P. Efentakis, 2013, European journal of pharmacology.

Metabolic Factors, Cardiac Structure, and Cardiac Function Epicardial Fat in Nonalcoholic Fatty Liver Disease: Properties and Relationships With

E. Iliodromitis, D. Sassoon, H. Sacks, 2015 .

A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus.

A. Mebazaa, F. Fedele, E. Iliodromitis, 2019, International journal of cardiology.

C-Reactive Protein, Interleukin 6, and N-Terminal Pro-Brain Natriuretic Peptide Following Cardioversion of Atrial Fibrillation: Is There a Role of Biomarkers in Arrhythmia Recurrence?

E. Iliodromitis, D. Kremastinos, T. Apostolou, 2011, Angiology.

Lowering Interleukin-12 Activity Improves Myocardial and Vascular Function Compared With Tumor Necrosis Factor-a Antagonism or Cyclosporine in Psoriasis

J. Lekakis, I. Andreadou, E. Iliodromitis, 2017, Circulation. Cardiovascular imaging.

Anti-Thrombotic Therapy after Trans-Catheter Aortic Valve Implantation: Time for Refinement

E. Iliodromitis, D. Farmakis, 2018, Cardiology.

Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure.

S. Adamopoulos, E. Iliodromitis, J. Parissis, 2004, The American journal of cardiology.

Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function

J. Lekakis, I. Andreadou, E. Iliodromitis, 2019, Clinical Research in Cardiology.

Oral nicorandil recaptures the waned protection from preconditioning in vivo

A. Zoga, E. Iliodromitis, D. Kremastinos, 2003, British journal of pharmacology.

Protection from postconditioning depends on the number of short ischemic insults in anesthetized pigs

J. Downey, E. Iliodromitis, D. Kremastinos, 2006, Basic Research in Cardiology.

Prothrombotic genetic risk factors in patients with very early ST-segment elevation myocardial infarction

L. Rallidis, A. Gialeraki, Maria Rallidi, 2017, Journal of Thrombosis and Thrombolysis.

Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator

J. Downey, E. Iliodromitis, D. Kremastinos, 2007, Basic Research in Cardiology.

Eligibility for treatment with PCSK9 inhibitors among patients with stable coronary artery disease presumed to be on maximum hypolipidaemic therapy.

L. Rallidis, A. Triantafyllis, E. Iliodromitis, 2017, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Effects of Levosimendan on circulating markers of oxidative and nitrosative stress in patients with advanced heart failure.

G. Filippatos, A. Pyriochou, I. Andreadou, 2007, Atherosclerosis.

Biomarkers of myocardial injury as surrogate end-points for remote ischemic conditioning trials.

E. Iliodromitis, D. Farmakis, D. Kremastinos, 2011, International journal of cardiology.

Right atrial myxoma presenting as syncope due to pulmonary embolism in a previously asymptomatic patient.

B. Gogas, L. Rallidis, E. Iliodromitis, 2011, International Journal of Cardiology.

Short-term effects of right atrial, right ventricular apical, and atrioventricular sequential pacing on myocardial oxygen consumption and cardiac efficiency in patients with coronary artery disease.

E. Iliodromitis, D. Kremastinos, Z. Kyriakides, 1994, British heart journal.

Effects of Darbepoetin Alfa on plasma mediators of oxidative and nitrosative stress in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

G. Filippatos, I. Andreadou, E. Iliodromitis, 2009, The American journal of cardiology.

Prognostic value of tissue Doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic Peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

G. Filippatos, E. Iliodromitis, I. Paraskevaidis, 2010, The American journal of cardiology.

Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure

G. Filippatos, S. Adamopoulos, E. Iliodromitis, 2006, Heart.

Cangrelor in Ticagrelor-Loaded STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.

E. Iliodromitis, I. Xanthopoulou, D. Alexopoulos, 2018, Journal of the American College of Cardiology.

HEllenic Registry on Myocarditis SyndromES on behalf of Hellenic Heart Failure Association: The HERMES‐HF Registry

G. Filippatos, S. Adamopoulos, F. Triposkiadis, 2020, ESC Heart Failure.

Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19

I. Andreadou, E. Iliodromitis, J. Parissis, 2020, Food and Chemical Toxicology.

Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019

G. Dangas, M. Cleman, K. Syrigos, 2020, JAMA network open.

Pulmonary veno-occlusive disease associated with long-term occupational exposure to chemical solvents and pesticides. A case report.

M. Humbert, E. Iliodromitis, D. Montani, 2022, Respiratory medicine and research.

Synthesis and Pharmacological Evaluation of Novel Adenine-Hydrogen Sulfide Slow Release Hybrids Designed as Multitarget Cardioprotective Agents.

A. Papapetropoulos, I. Andreadou, P. Efentakis, 2016, Journal of medicinal chemistry.

Electronic Cigarette Smoking Increases Arterial Stiffness and Oxidative Stress to a Lesser Extent Than a Single Conventional Cigarette: An Acute and Chronic Study.

J. Lekakis, I. Andreadou, P. Efentakis, 2018, Circulation.

Double organ transplantation in cardiac amyloidosis.

S. Adamopoulos, E. Iliodromitis, D. Farmakis, 2016, Journal of cardiovascular medicine.

Staccato reperfusion improves myocardial microcirculatory function and long-term left ventricular remodelling: a randomised contrast echocardiography study

I. Andreadou, E. Iliodromitis, I. Paraskevaidis, 2010, Heart.

Association of non‐invasive electrocardiographic risk factors with left ventricular systolic function in post‐myocardial infarction patients with mildly reduced or preserved ejection fraction: Insights from the PRESERVE‐EF study

S. Sideris, D. Tousoulis, E. Iliodromitis, 2022, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose dependent manner: Implications for inotropy.

N. Kostomitsopoulos, D. Sanoudou, T. Suter, 2020, Cardiovascular research.

Intracoronary and systemic release of the atrial natriuretic factor and cyclic-guanosine monophosphate during coronary angioplasty

E. Iliodromitis, D. Kremastinos, Z. Kyriakides, 1996, Letters in Peptide Science.

Atrial natriuretic peptide augments coronary collateral blood flow: A study during coronary angioplasty

E. Iliodromitis, D. Kremastinos, Z. Kyriakides, 1998, Clinical cardiology.

Peripheral vein plasma endothelin-1 levels during coronary angioplasty increase only in normotensive patients

D. Tsiapras, E. Iliodromitis, D. Kremastinos, 1994, Cardiovascular Drugs and Therapy.

Studies on Atrial Fibrillation in Humans: Atrial Mapping and Attempts at Catheter Ablation

A. Camm, E. Iliodromitis, I. Paraskevaidis, 1998 .

The effects of tirofiban on peripheral markers of oxidative stress and endothelial dysfunction in patients with acute coronary syndromes.

S. Kyrzopoulos, I. Andreadou, E. Iliodromitis, 2007, Thrombosis research.

Plasma levels of osteopontin before and 24 h after percutaneous coronary intervention

C. Varounis, I. Andreadou, E. Iliodromitis, 2008 .

Multiple cycles of preconditioning cause loss of protection in open-chest rabbits.

E. Iliodromitis, D. Kremastinos, D. Katritsis, 1997, Journal of molecular and cellular cardiology.

Design and synthesis of novel antihypertensive drugs.

A. Zoga, E. Iliodromitis, T. Mavromoustakos, 2003, Bioorganic & medicinal chemistry letters.

Pharmacological postconditioning of the rabbit heart with non‐selective, A1, A2A and A3 adenosine receptor agonists

N. Dagres, I. Andreadou, A. Zoga, 2014, The Journal of pharmacy and pharmacology.

Prediction of ventricular arrhythmias using cardiovascular magnetic resonance.

Sophie Mavrogeni, George Theodorakis, G. Kolovou, 2013, European heart journal cardiovascular Imaging.

Letter by Iliodromitis et al regarding article, "Cardiac Ischemic Preconditioning in Coronary Stenting (CRISP Stent) study: a prospective, randomized control trial".

E. Iliodromitis, D. Kremastinos, K. G. Kolocassides, 2009, Circulation.

Chronic Empaglifozin treatment reduces myocardial infarct size in non-diabetic mice through STAT-3 mediated protection on microvascular endothelial cells and reduction of oxidative stress.

A. Vlahou, M. Brizzi, N. Kostomitsopoulos, 2020, Antioxidants & redox signaling.

Remote Ischemic Conditioning: more explanations and more expectations

J. Downey, E. Iliodromitis, M. Cohen, 2022, Basic Research in Cardiology.

Saffron (Crocus sativus) intake provides nutritional preconditioning against myocardial ischemia-reperfusion injury in Wild Type and ApoE(-/-) mice: Involvement of Nrf2 activation.

N. Kostomitsopoulos, R. León, I. Andreadou, 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Hydrogen sulfide and PKG in ischemia–reperfusion injury: sources, signaling, accelerators and brakes

A. Papapetropoulos, I. Andreadou, E. Iliodromitis, 2015, Basic Research in Cardiology.

Ligands involved in conditioning may enhance the protection afforded by remote ischemia and reperfusion.

I. Andreadou, E. Iliodromitis, D. Farmakis, 2015, International journal of cardiology.

Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost

P. Ferdinandy, F. Triposkiadis, I. Andreadou, 2022, International journal of molecular sciences.

Very high-risk familial hypercholesterolaemia patients in real life: The remaining gap in achieving the current LDL-C targets despite the use of PCSK9 inhibitors.

C. Vlachopoulos, G. Kolovou, L. Rallidis, 2020, Atherosclerosis.

REMOTE ISCHAEMIC PRECONDITIONING AND POSTCONDITIONING AND THE REPERFUSION INJURY SALVAGE KINASE PATHWAY

D. Yellon, E. Iliodromitis, D. Kremastinos, 2009 .

Peak exercise myocardial deformation indices during cardiopulmonary exercise testing are associated with exercise capacity and ventilatory efficiency in patients with dilated cardiomyopathy.

F. Triposkiadis, E. Iliodromitis, D. Cokkinos, 2022, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Prognostic significance of global longitudinal strain in chronic kidney disease: the evidence is building

E. Iliodromitis, I. Andreou, J. Parissis, 2018, European journal of heart failure.

Synthesis and study of a cyclic angiotensin II antagonist analogue reveals the role of pi*--pi* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT(1) non-peptide antagonists.

T Mavromoustakos, E. Iliodromitis, J. Matsoukas, 2001, Bioorganic & medicinal chemistry.

The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits.

A. Tsantili-Kakoulidou, I. Andreadou, A. Skaltsounis, 2006, The Journal of nutrition.

Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress.

V. Gorgoulis, I. Andreadou, E. Iliodromitis, 2007, Journal of molecular and cellular cardiology.

Inverse relation of C-reactive protein levels to heart rate variability in patients after acute myocardial infarction.

G. Liakos, E. Iliodromitis, D. Kremastinos, 2007, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Antioxidant activity of novel indole derivatives and protection of the myocardial damage in rabbits.

A. Tsantili-Kakoulidou, I. Andreadou, E. Iliodromitis, 2002, Chemical & pharmaceutical bulletin.

"Pistacia lentiscus L." reduces the infarct size in normal fed anesthetized rabbits and possess antiatheromatic and hypolipidemic activity in cholesterol fed rabbits.

I. Andreadou, P. Efentakis, E. Iliodromitis, 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Diabetes Mellitus and Heart Failure

R. Starling, F. Triposkiadis, J. Skoularigis, 2021, Journal of clinical medicine.

Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance.

D. Tsiapras, E. Iliodromitis, I. Paraskevaidis, 2005, European heart journal.

Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection

H. Bøtker, Z. Giricz, P. Ferdinandy, 2018, Basic Research in Cardiology.

Association of impaired endothelial glycocalyx with arterial stiffness, coronary microcirculatory dysfunction, and abnormal myocardial deformation in untreated hypertensives

J. Lekakis, E. Iliodromitis, J. Parissis, 2018, Journal of clinical hypertension.

ACE2, the Counter-Regulatory Renin–Angiotensin System Axis and COVID-19 Severity

R. Starling, F. Triposkiadis, J. Skoularigis, 2021, Journal of clinical medicine.

Sphenopalatine ganglion block: an external gate to modulate cardiac autonomic tone and suppress premature ventricular beats?

E. Iliodromitis, G. Kostopanagiotou, S. Deftereos, 2018, Annals of translational medicine.

The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design

M. Lazanas, M. Cleman, C. Stefanadis, 2020, Hellenic Journal of Cardiology.

Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis.

G. Hindricks, J. Lekakis, L. Rallidis, 2011, Journal of cardiac failure.

The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation.

I. Andreadou, E. Iliodromitis, J. Parissis, 2009, International journal of cardiology.

Tissue Doppler Imaging Analysis at Pre‐Cardioversion Time Predicts Recurrent Atrial Fibrillation: A 12‐Month Follow‐Up Study

V. Vartela, D. Tsiapras, E. Iliodromitis, 2006, Journal of cardiovascular electrophysiology.

Two-dimensional strain analysis in patients with hypertrophic cardiomyopathy and normal systolic function: a 12-month follow-up study.

E. Iliodromitis, I. Paraskevaidis, D. Farmakis, 2009, American heart journal.

Ranolazine for the prevention or treatment of atrial fibrillation: a systematic review

J. Lekakis, L. Rallidis, N. Dagres, 2014, Journal of cardiovascular medicine.

Ablation therapy of type I atrial flutter may eradicate paroxysmal atrial fibrillation.

S. Adamopoulos, E. Iliodromitis, D. Kremastinos, 1996, The American journal of cardiology.

Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity

G. Filippatos, A. Mebazaa, F. Follath, 2014, Clinical Research in Cardiology.

Reciprocal regulation of eNOS, H2S and CO-synthesizing enzymes in human atheroma: Correlation with plaque stability and effects of simvastatin

A. Papapetropoulos, I. Andreadou, P. Efentakis, 2017, Redox biology.

Acute administration of the olive constituent, oleuropein, combined with ischemic postconditioning increases myocardial protection by modulating oxidative defense.

N. Kostomitsopoulos, O. Tsitsilonis, A. Papapetropoulos, 2021, Free radical biology & medicine.

Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors.

N. Kostomitsopoulos, A. Tsantili-Kakoulidou, A. Papapetropoulos, 2019, Cardiovascular research.

Reduction of myocardial infarct size in rabbits by a novel indole derivative with antioxidant and free radical scavenging properties.

A. Tsantili-Kakoulidou, I. Andreadou, E. Iliodromitis, 2002, European journal of pharmacology.

Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress.

A. Papapetropoulos, I. Andreadou, A. Zoga, 2012, Cardiovascular research.

QT‐interval dispersion in acute myocardial infarction is only shortened by thrombolysis in myocardial infarction grade 2/3 reperfusion

E. Iliodromitis, D. Cokkinos, V. Voudris, 2003, Clinical cardiology.

Remote Ischemic Conditioning: more explanations and more expectations

J. Downey, E. Iliodromitis, M. Cohen, 2022, Basic Research in Cardiology.

Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein

A. Tsantili-Kakoulidou, I. Andreadou, A. Skaltsounis, 2009, NMR in biomedicine.

Ventricular long-axis contraction as an earlier predictor of outcome in asymptomatic aortic regurgitation.

S. Kyrzopoulos, D. Tsiapras, E. Iliodromitis, 2007, The American journal of cardiology.

The role of left ventricular long-axis contraction in patients with asymptomatic aortic regurgitation.

S. Kyrzopoulos, D. Tsiapras, E. Iliodromitis, 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?

A. Vlahou, N. Kostomitsopoulos, G. Dimitriadis, 2022, Basic Research in Cardiology.

Plasma B-type natriuretic peptide reduction predicts long-term response to levosimendan therapy in acutely decompensated chronic heart failure.

G. Filippatos, E. Iliodromitis, I. Paraskevaidis, 2010, International journal of cardiology.

Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.

G. Filippatos, M. Gheorghiade, S. Adamopoulos, 2006, The American journal of cardiology.

Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability.

V. Gorgoulis, A. Kotsinas, I. Andreadou, 2010, Journal of vascular surgery.

Severe anaemia and subcapital femur fracture in a patient with Left Ventricular Assist Device Heart Mate II: the cardiologist's management of this rare patient

G. Filippatos, M. Yacoub, B. Gogas, 2009, European journal of heart failure.

Ischemic preconditioning: Protection against myocardial necrosis and apoptosis

E. Iliodromitis, A. Lazou, D. Kremastinos, 2007, Vascular health and risk management.

Type 2 Diabetes Mellitus Treatment and Beyond

E. Iliodromitis, K. Iliodromitis, 2023, JACC. Basic to translational science.

Cellular Communications in the Heart.

N. Dagres, E. Iliodromitis, K. Fountoulaki, 2015, Cardiac failure review.

Cardiopulmonary Exercise Test Parameters at Three Months After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy Are Associated With Late Clinical Outcome.

E. Sakadakis, E. Iliodromitis, H. Triantafyllidi, 2020, Heart, lung & circulation.

Chronic hind limb ischemia reduces myocardial ischemia-reperfusion injury in the rabbit heart by promoting coronary angiogenesis/arteriogenesis.

A. Zoga, E. Iliodromitis, D. Kremastinos, 2010, In vivo.

Evaluation of left atrial longitudinal function in patients with hypertrophic cardiomyopathy: a tissue Doppler imaging and two-dimensional strain study

E. Iliodromitis, I. Paraskevaidis, D. Farmakis, 2008, Heart.

Research update for articles published in EJCI in 2010

C. Datz, G. Pascual, J. Bellón, 2012 .

Alternative pharmacological interventions that limit myocardial infarction.

I. Andreadou, E. Iliodromitis, A. Tsotinis, 2008, Current medicinal chemistry.

Acute administration of vitamin C abrogates protection from ischemic preconditioning in rabbits.

I. Andreadou, A. Zoga, E. Iliodromitis, 2008, Pharmacological research.

Hypertension study in anaesthetized rabbits: protocol proposal for AT1 antagonists screening

A. Zoga, E. Iliodromitis, T. Mavromoustakos, 2010, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Temporal changes of noninvasive electrocardiographic risk factors for sudden cardiac death in post‐myocardial infarction patients with preserved ejection fraction: Insights from the PRESERVE‐EF study

E. Brilakis, D. Tousoulis, E. Iliodromitis, 2020, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Antiatheromatic and hypolipidemic activity of Chios Mastic Gum in anesthetized rabbits

I. Andreadou, A. Zoga, A. Skaltsounis, 2008 .

Cardiopulmonary exercise testing: Is it time to be included in a routine checkup for a relatively healthy population?

E. Iliodromitis, H. Triantafyllidi, D. Benas, 2022, International journal of cardiology.

Reference values for aerobic capacity estimated by cardiopulmonary exercise test on a cycle ergometer in a healthy Greek population.

E. Iliodromitis, H. Triantafyllidi, P. Trivilou, 2019, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits.

I. Andreadou, A. Zoga, E. Iliodromitis, 2006, Atherosclerosis.

Intracoronary cyclic-GMP and cyclic-AMP during percutaneous transluminal coronary angioplasty.

E. Iliodromitis, D. Kremastinos, Z. Kyriakides, 1996, International journal of cardiology.

Pharmacological pre- and post- conditioning agents: reperfusion-injury of the heart revisited.

I. Andreadou, E. Iliodromitis, D. Kremastinos, 2008, Mini reviews in medicinal chemistry.

The effectiveness of beta-blockade and its influence on heart rate variability in vasovagal patients.

P. Toutouzas, E. Iliodromitis, D. Kremastinos, 1993, European heart journal.

Long term outcome and quality of life following acute type A aortic dissection.

E. Iliodromitis, A. Analitis, P. Georgiadou, 2021, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Investigating the Effect of Antioxidant Treatment on the Protective Effect of Preconditioning in Anesthetized Rabbits

A. Tsantili-Kakoulidou, N. Dagres, I. Andreadou, 2011, Journal of cardiovascular pharmacology.

Design, synthesis and biological evaluation of cyclic angiotensin II analogues with 3,5 side-chain bridges. Role of C-terminal aromatic residue and ring cluster for activity and implications in the drug design of AT1 non-peptide antagonists.

Panagiotis Zoumpoulakis, Simona Golic Grdadolnik, Ilze Mutule, 2002, Bioorganic & medicinal chemistry letters.

Ovariectomy Reinstates the Infarct Size-Limiting Effect of Postconditioning in Female Rabbits

I. Andreadou, A. Zoga, E. Iliodromitis, 2013, Cell Biochemistry and Biophysics.

Association of hydroxytyrosol enriched olive oil with vascular function in chronic coronary disease

F. Triposkiadis, I. Andreadou, E. Iliodromitis, 2023, European journal of clinical investigation.

Synthesis, binding studies and in vivo biological evaluation of novel non-peptide antihypertensive analogues.

A. Balmforth, J. Findlay, A. Zoga, 2006, Bioorganic & medicinal chemistry.

Left ventricular assist device vegetation: "cure" without device explantation.

M. Yacoub, B. Gogas, E. Iliodromitis, 2010, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

The role of left ventricular long axis contraction in patients with asymptomatic non-ischemic mitral valve regurgitation and normal systolic function.

S. Kyrzopoulos, D. Tsiapras, E. Iliodromitis, 2008, International journal of cardiology.

Hyperlipidemia prevents the expected reduction of myocardial ischemia on repeated balloon inflations during angioplasty.

E. Iliodromitis, D. Kremastinos, T. Kolettis, 2002, Chest.

Dronedarone and the Incidence of Stroke in Patients with Paroxysmal or Persistent Atrial Fibrillation

J. Lekakis, L. Rallidis, C. Varounis, 2011, American journal of cardiovascular drugs : drugs, devices, and other interventions.

Pulse wave velocity to global longitudinal strain ratio in hypertension

J. Lekakis, E. Iliodromitis, J. Parissis, 2018, European journal of clinical investigation.

The Role of the Selective Serotonin Re‐Uptake Inhibitor Sertraline in Nondepressive Patients with Chronic Ischemic Heart Failure: A Preliminary Study

E. Iliodromitis, I. Paraskevaidis, D. Kremastinos, 2010, Pacing and clinical electrophysiology : PACE.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of

B. Lewis, J. Mehilli, S. Windecker, 2016 .

The burden of atrial fibrillation and heart failure in hospitalized patients. A real-world survey in a nationwide snapshot.

L. Michalis, D. Tousoulis, F. Triposkiadis, 2023, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Vein plasma endothelin-1 and cyclic GMP increase during coronary angioplasty is related to myocardial ischaemia.

E. Iliodromitis, Z. Kyriakides, M. Markianos, 1995, European Heart Journal.

Cangrelor in Ticagrelor-Loaded STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.

E. Iliodromitis, I. Xanthopoulou, D. Alexopoulos, 2018, Journal of the American College of Cardiology.

Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function

J. Lekakis, I. Andreadou, E. Iliodromitis, 2019, Clinical Research in Cardiology.

Ischemic preconditioning: Protection against myocardial necrosis and apoptosis

E. Iliodromitis, A. Lazou, D. Kremastinos, 2007, Vascular health and risk management.

Exposure to cigarette smoke abrogates the beneficial effect of ischemic postconditioning.

S. Zakynthinos, A. Papapetropoulos, I. Andreadou, 2016, American journal of physiology. Heart and circulatory physiology.

What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets

J. Downey, N. Dagres, I. Andreadou, 2015, Journal of cardiovascular pharmacology and therapeutics.

Conformational and biological studies for a pair of novel synthetic AT1 antagonists: stereoelectronic requirements for antihypertensive efficacy.

T Mavromoustakos, S. Grdadolnik, A. Zoga, 2003, Journal of pharmaceutical and biomedical analysis.

Differential activation of mitogen-activated protein kinases in ischemic and nitroglycerin-induced

A. Zoga, E. Iliodromitis, A. Lazou, 2006 .

Instantaneous electrocardiographic changes and transient sinus rhythm restoration in severe hyperkalaemia.

B. Gogas, L. Rallidis, E. Iliodromitis, 2011, International journal of cardiology.

O R I G I N a L I N V E S T I G a T I O N Open Access

G. Dimitriadis, E. Iliodromitis, J. Parissis, 2022 .